Literature DB >> 25686645

Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.

Lurdes Zamora1, Blanca Xicoy1, Marta Cabezón1, Cristalina Fernandez2, Silvia Marcé1, Patricia Velez3, Marisol Xandri1, David Gallardo2, Fuensanta Millá1, Evarist Feliu1, Concepción Boqué3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25686645     DOI： 10.3109/10428194.2015.1015124

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

Authors:  Munazza Rashid; Rifat Zubair Ahmed; Shariq Ahmed; Muhammad Nadeem; Nuzhat Ahmed; Tahir Sultan Shamsi
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-09       Impact factor: 0.900

2.  Buccal epithelial cells display somatic, bone marrow-derived CALR mutation.

Authors:  Scott R Gilles; Linda B Baughn; Matthew L Schomaker; Elizabeth L Courville; Andrew C Nelson; Zohar Sachs
Journal:  Blood Adv       Date:  2017-11-16

Review 3.  Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions.

Authors:  Ruochen Jia; Robert Kralovics
Journal:  Int J Hematol       Date:  2019-11-18       Impact factor: 2.490

4.  The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.

Authors:  Margherita Perricone; Nicola Polverelli; Giovanni Martinelli; Lucia Catani; Emanuela Ottaviani; Elisa Zuffa; Eugenia Franchini; Arbana Dizdari; Dorian Forte; Elena Sabattini; Michele Cavo; Nicola Vianelli; Francesca Palandri
Journal:  Oncotarget       Date:  2017-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.